EcoDrugPlus

Proteasome Subunit Alpha Type-6-Like

Ensembl ID : ENSEEEG00000010167
Gene Symbol: LOC113571685
4 Cross references
262 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSEEEG00000019382
Gene Symbol: PRMT5
4 Cross references
199 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSEEEG00000017298
Gene Symbol: PRKCD
2 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSEEEG00000010415
Gene Symbol: PRKCE
4 Cross references
268 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSEEEG00000017048
Gene Symbol: PRKCE
4 Cross references
251 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSEEEG00000002078
Gene Symbol: PRKCAA
2 Cross references
156 Possible Orthologues:

Protein Kinase C, Beta A

Ensembl ID : ENSEEEG00000016653
Gene Symbol: PRKCBA
4 Cross references
201 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSEEEG00000009815
Gene Symbol: PRKCDA
4 Cross references
205 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSEEEG00000023164
Gene Symbol: PRKCHA
2 Cross references
220 Possible Orthologues:

Protein Kinase C, Eta, B

Ensembl ID : ENSEEEG00000023784
Gene Symbol: PRKCHB
4 Cross references
161 Possible Orthologues:

Protein Kinase C, Iota

Ensembl ID : ENSEEEG00000015700
Gene Symbol: PRKCI
4 Cross references
270 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSEEEG00000015326
Gene Symbol: PRKCQ
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).